ThinkSabio

$XRTX

$1.95▲ +11.4% YTD

4 SEC 13D/G filings tracked · Last updated Oct 8, 2026

Filing History
News
XRTX ▲ +11.4% - XORTX Therapeutics Inc.
CP $1.95▲ +11.4%Oct 8, 2026 · ThinkSabio Blog

$XRTX - XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout…

News
XRTX ▲ +21.9% - XORTX Therapeutics Inc.
CP $2.06▲ +21.9%Sep 18, 2026 · ThinkSabio Blog

$XRTX - XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity…

News
XRTX ▲ +15.7% - XORTX Therapeutics Inc.
CP $2.50▲ +15.7%Sep 10, 2026 · ThinkSabio Blog

$XRTX - XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™…

News
XRTX ▲ +1.2% - XORTX Therapeutics Inc.
CP $2.47▲ +1.2%Aug 28, 2026 · ThinkSabio Blog

$XRTX - XORTX Announces Termination and Postponement of Investor Relations Program…